Harvoni (ledipasvir/sofosbuvir) is a prescription drug that’s used to help treat certain types of hepatitis C. The drug comes as oral tablets and oral pellets. You ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and certain children. As with other drugs, Harvoni can cause side ...

The Food and Drug Administration on April 7 approved Sovaldi and Harvoni to treat the hepatitis C virus in patients ages 12 to 17. The drugs, developed by Gilead Sciences, represent the first ...

* Studies demonstrated HCV cure rates of 99 percent in children aged 6 to 11 years, and 100 percent in adult patients co-infected with HCV and HBV * In Karen Murray led study, 1 treatment-naïve ...

(Reuters) - Gilead Sciences Inc on Tuesday said its new Harvoni drug for hepatitis C achieved cure rates of 96 percent to 97 percent in a study of patients who had cirrhosis and had failed to benefit ...

As payers push back on the pricing of Gilead's hepatitis C drugs Sovaldi and Harvoni, the Foster City-based drug developer has big plans for the drugs — and others — in Japan. Gilead Sciences Inc.

The new diabetes test helps identify patients with type 1 diabetes The FDA has approved Harvoni (ledipasvir/sofosbuvir; Gilead Sciences), the first once-daily single ...

Counterfeits of Gilead’s mega-blockbuster hepatitis C treatment Harvoni, which is generating billions per quarter in sales for the company, are emerging in Israel. Switzerland’s drug regulator ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Harvoni comes as oral tablets and pellets that ...